NO940008D0 - Tablettering av colestipolhydroklorid - Google Patents

Tablettering av colestipolhydroklorid

Info

Publication number
NO940008D0
NO940008D0 NO940008A NO940008A NO940008D0 NO 940008 D0 NO940008 D0 NO 940008D0 NO 940008 A NO940008 A NO 940008A NO 940008 A NO940008 A NO 940008A NO 940008 D0 NO940008 D0 NO 940008D0
Authority
NO
Norway
Prior art keywords
tablet
tablets
scus
mins
excipients
Prior art date
Application number
NO940008A
Other languages
English (en)
Other versions
NO940008L (no
NO307686B1 (no
Inventor
Robert Wu-Wei Shen
Jeffrey Ellis Price
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO940008D0 publication Critical patent/NO940008D0/no
Publication of NO940008L publication Critical patent/NO940008L/no
Publication of NO307686B1 publication Critical patent/NO307686B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO940008A 1991-07-03 1994-01-03 Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter NO307686B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72504491A 1991-07-03 1991-07-03
PCT/US1992/005066 WO1993000915A1 (en) 1991-07-03 1992-06-23 Colestipol hydrochloride high-content tablets

Publications (3)

Publication Number Publication Date
NO940008D0 true NO940008D0 (no) 1994-01-03
NO940008L NO940008L (no) 1994-01-03
NO307686B1 NO307686B1 (no) 2000-05-15

Family

ID=24912923

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940008A NO307686B1 (no) 1991-07-03 1994-01-03 Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter

Country Status (18)

Country Link
US (1) US5490987A (no)
EP (1) EP0592594B1 (no)
JP (1) JP3313710B2 (no)
KR (1) KR100240362B1 (no)
AT (1) ATE173931T1 (no)
AU (1) AU669664B2 (no)
CA (1) CA2110166C (no)
CZ (1) CZ286958B6 (no)
DE (1) DE69227773T2 (no)
DK (1) DK0592594T3 (no)
ES (1) ES2124736T3 (no)
FI (1) FI106843B (no)
HU (1) HU222242B1 (no)
NO (1) NO307686B1 (no)
PL (1) PL169045B1 (no)
RU (1) RU2108090C1 (no)
SK (1) SK281920B6 (no)
WO (1) WO1993000915A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
CZ20021344A3 (cs) * 1999-10-19 2002-08-14 Geltex Pharmaceuticals, Inc. Tableta obsahující jádro a potahování a stlačená tableta
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
CA2551528A1 (en) * 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
CA2620406A1 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP1924246B1 (en) 2005-09-15 2015-10-21 Genzyme Corporation Sachet formulation for amine polymers
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
CA2661987C (en) * 2006-09-01 2012-11-06 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
BRPI0717545A2 (pt) 2006-09-29 2013-10-22 Gezyme Corp Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
JP2010513271A (ja) 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
WO2010041268A2 (en) * 2008-09-02 2010-04-15 Usv Limited Crosslinked polymers
WO2010086881A2 (en) * 2009-01-22 2010-08-05 Usv Limited Pharmaceutical compositions comprising phosphate-binding polymer
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
ZA804914B (en) * 1979-08-29 1981-08-26 Rohm & Haas The production of powdered resin and the powdered resin so produced
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4404346A (en) * 1980-08-05 1983-09-13 Rohm And Haas Company Production of powdered resin and the powdered resin so produced
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
WO1989012452A1 (en) * 1988-06-24 1989-12-28 The Upjohn Company Fine-milled colestipol hydrochloride
KR900701285A (ko) * 1988-08-26 1990-12-01 로버어트 에이 아미테이지 미세-구슬상 콜레스티폴 염산염

Also Published As

Publication number Publication date
ES2124736T3 (es) 1999-02-16
ATE173931T1 (de) 1998-12-15
PL169045B1 (pl) 1996-05-31
SK281920B6 (sk) 2001-09-11
FI106843B (fi) 2001-04-30
HU222242B1 (hu) 2003-05-28
EP0592594A1 (en) 1994-04-20
AU669664B2 (en) 1996-06-20
WO1993000915A1 (en) 1993-01-21
JPH06509097A (ja) 1994-10-13
CZ286958B6 (cs) 2000-08-16
AU2293392A (en) 1993-02-11
SK194A3 (en) 1994-11-09
DE69227773D1 (de) 1999-01-14
NO940008L (no) 1994-01-03
FI935943A0 (fi) 1993-12-30
CA2110166C (en) 2002-11-05
DK0592594T3 (da) 1999-08-16
DE69227773T2 (de) 1999-05-20
JP3313710B2 (ja) 2002-08-12
HU9400004D0 (en) 1994-05-30
CA2110166A1 (en) 1993-01-21
EP0592594B1 (en) 1998-12-02
KR100240362B1 (ko) 2000-02-01
US5490987A (en) 1996-02-13
HUT69394A (en) 1995-09-28
NO307686B1 (no) 2000-05-15
CZ282693A3 (en) 1994-06-15
RU2108090C1 (ru) 1998-04-10
FI935943A (fi) 1993-12-30

Similar Documents

Publication Publication Date Title
FI935943A (fi) Tablettering av kolestipolhydroklorid
US4990535A (en) Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
MX9500243A (es) Composicion de liberacion acelerada que contiene bromocriptina.
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
CA2106172A1 (en) Use of 2-(3,4-Dimethoxycinnamoyl)Aminobenzoic Acid for the Treatment of Restenosis Associated with Coronary Intervention
NO942325D0 (no) Transdermalt administrert system som inneholder acetylsalicylsyre for tromboseterapi og cancerprofylakse
MX173567B (es) Procedimiento para preparar una composicion farmaceutica y composicion farmaceutica para mejorar los sintomas de enfermedad inducida por vih o reducir la transcripcion y proliferacion del vih
NO308644B1 (no) Anvendelse av 4-aminopyridin for fremstilling av et farmasøytisk preparat
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
ATE258788T1 (de) Tablette
KR950013513A (ko) 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제
Lim et al. The antiemetic and sysphoric effects of droperidol in the day surgery patient
BG101803A (en) Use of melatonin for treating patients suffering from drug addiction
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
YU56702A (sh) Korišćenje fsh za lečenje neplodnosti
Ockelford et al. A double-blind placebo controlled trial to study the efficacy and safety of a low molecular weight heparin fragment (Fragmin) in patients having major elective general surgery
ES2042831T3 (es) Procedimiento de preparacion de una composicion farmaceutica para el tratamiento de la osteoporosis.
Gumpel Cyclophosphamide, gold and penicillamine—disease-modifying drugs in rheumatoid arthritis—tailored dosage and ultimate success
Taylor et al. Laparoscopic vagotomy: an operation for the 1990s?
Segal et al. A polyamine formaldehyde resin IV. Clinical evaluation in the treatment of duodenal ulcer
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
GB2174004A (en) Effervescent tablets
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
EP0681476B1 (en) Unit dose form of bismuth subsalicylate

Legal Events

Date Code Title Description
MK1K Patent expired